Sionna Therapeutics Completes $182 Million Series C
$182 Top Quintile $1,420 80–90th Percent $505 90–95th Percent $907 95–99th Percent $1,828 Top 1 Percent $11,474 Source: Tax Policy Center, T11–0253, Tax
Solo D5353 Warren Executive Leather Briefcase Espresso Retail $182 $182 $182 Top Quintile $1,420 80–90th Percent $505 90–95th Percent $907 95–99th Percent $1,828 Top 1 Percent $11,474 Source: Tax Policy Center, T11–0253, Tax convert $182 Source: Financial Review By: Simon Evans Singapore's ComfortDelGro has made a $182 million buyout offer for A2B Australia, the operator of
$182 Sionna raises $182m to double down in cystic fibrosis drug development Sionna could have four candidates in clinical trials in 2024 amid a
Regular
price
164.00 ₹ INR
Regular
price
Sale
price
164.00 ₹ INR
Unit price
/
per